Stocks
Cipla Limited
Corporate announcements
1585 records, the earliest from 11 Nov 2010. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.
1585 shown.
Sign in to see more, or upgrade your plan to see the full history.
Sign in
Date Category Subject 28 Sep 2026 Board Meeting
Cipla Ltd - 500087 - Board Meeting Intimation for The Quarter And Half Year Ended 30Th September, 2026 Under SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
24 Sep 202613:33
ESOP/ESOS/ESPS
Cipla Limited has informed the Exchange regarding Allotment of 12168 Shares. 22 Sep 202617:27
Change in Management
Cipla Limited has informed the Exchange about change in Senior Management Personnel. 18 Sep 2026 Company Update
Cipla Ltd - 500087 - Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 18 Sep 202612:02
General Updates
Intimation under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 3 Sep 202614:43
Press Release
Cipla Limited has informed the Exchange regarding a press release dated September 03, 2026, titled "Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda® (Pembrolizumab) in the US". 3 Sep 202611:19
General Updates
Notice to shareholders and creditors in accordance with NCLT Order dated 18th August, 2026 regarding merger of Inzpera Healthsciences Limited with the Company. 2 Sep 202614:32
Copy of Newspaper Publication
Cipla Limited has informed the Exchange about Newspaper Publication regarding opening of special window for re-lodgement of transfer and dematerialisation of physical shares 31 Aug 202610:23
Press Release
Cipla Limited has informed the Exchange regarding a press release dated August 31, 2026, titled "Cipla and SBP Group sign exclusive licensing agreement for potential best-in-class HER2 bispecific ADC Rolditamig Deuderuxtecan (TQB2102)". 28 Aug 202615:41
General Updates
Cipla Limited has informed the Exchange about Update on USFDA inspection at InvaGen manufacturing facility in Central Islip, Long Island, NY, USA
Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.
